Covered recipient · General Payments record
JASON M CASTRO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$418.74
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $191.59 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $42.18 | 2 |
| Novo Nordisk AS | $36.65 | 2 |
| Amgen Inc. | $36.43 | 2 |
| Abbott Laboratories | $21.58 | 1 |
| Tempus AI, Inc | $19.45 | 1 |
| GlaxoSmithKline, LLC. | $18.91 | 1 |
| ABBVIE INC. | $16.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.58 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124872987 | CMS |
| ABBVIE INC. | $16.39 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103428350 | CMS |
| Amgen Inc. | $22.56 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111544263 | CMS |
| Amgen Inc. | $13.87 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117220100 | CMS |
| GlaxoSmithKline, LLC. | $18.91 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116524682 | CMS |
| Novo Nordisk Inc | $21.82 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097772223 | CMS |
| Novo Nordisk Inc | $14.83 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097687814 | CMS |
| PFIZER INC. | $16.74 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131244747 | CMS |
| PFIZER INC. | $25.44 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131208235 | CMS |
| Tempus AI, Inc | $19.45 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150162195 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.